Search all trials

Find therapies in clinical trials near you – page 8

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 968
countries: 28
conditions: 2 103

3 968 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Age-related macular degeneration

Recruiting

A Phase 2/3 Study of intravitreal mk-8748 versus aflibercept in adults with neovascular age‑related macular degeneration

Registered drugNo placebo

A Phase 2/3 Study of intravitreal mk-8748 versus aflibercept in adults with neovascular age‑related macular degeneration

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Aflibercept

Contact Research Centre

Factor VIII deficiency

Recruiting

Evaluation of NXT007 versus Emicizumab Prophylaxis in Patients with Hemophilia A

Registered drugNo placebo

Evaluation of NXT007 versus Emicizumab Prophylaxis in Patients with Hemophilia A

Registered drugNo placebo

Denmark

Participants:0–17 years · 18–64 years · 65+ years
Substances:Emicizumab

Contact Research Centre

Factor VIII deficiency

Recruiting

A Phase III study of NXT007 compared with simoctocog alfa prophylaxis in patients with Hemophilia A without inhibitors

Registered drugNo placebo

A Phase III study of NXT007 compared with simoctocog alfa prophylaxis in patients with Hemophilia A without inhibitors

Registered drugNo placebo

Denmark

Participants:0–17 years · 18–64 years · 65+ years
Substances:Ro7589655

Contact Research Centre

Alpha-1 antitrypsin deficiency

Recruiting

Efficacy and safety of human alpha1‑proteinase inhibitor weekly infusions in adults with alpha1 antitrypsin deficiency–related emphysema

Registered drugNo placebo

Efficacy and safety of human alpha1‑proteinase inhibitor weekly infusions in adults with alpha1 antitrypsin deficiency–related emphysema

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Human Alpha1-Proteinase Inhibitor

Contact Research Centre

Rheumatoid arthritis

Recruiting

Long‑Term Safety and Efficacy of RO7790121 in Adults with Moderate to Severe Rheumatoid Arthritis: Extension Study

Investigational

Long‑Term Safety and Efficacy of RO7790121 in Adults with Moderate to Severe Rheumatoid Arthritis: Extension Study

Investigational

Denmark

Participants:18–64 years · 65+ years
Substances:Ro7790121

Contact Research Centre

Crohn's disease

Recruiting

A Phase 3b Study of Guselkumab Compared with Risankizumab in Adults with Moderately to Severely Active Crohn’s Disease

Registered drugNo placebo

A Phase 3b Study of Guselkumab Compared with Risankizumab in Adults with Moderately to Severely Active Crohn’s Disease

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Guselkumab

Contact Research Centre

Neoplasm

Recruiting

Safety and Efficacy of Ifinatamab Deruxtecan in Pediatric Patients Under 18 With Relapsed or Refractory Solid Tumors

InvestigationalNo placebo

Safety and Efficacy of Ifinatamab Deruxtecan in Pediatric Patients Under 18 With Relapsed or Refractory Solid Tumors

InvestigationalNo placebo

Denmark

Participants:0–17 years
Substances:Ifinatamab Deruxtecan

Contact Research Centre

Sepsis+1

Recruiting

Acetylcysteine for Adults with Acute Infection or Sepsis and Liver Dysfunction

Registered drug

Acetylcysteine for Adults with Acute Infection or Sepsis and Liver Dysfunction

Registered drug

Denmark

Participants:18–64 years · 65+ years
Substances:Acetylcysteine

Contact Research Centre

Study of ODM-212 in Combination with Cancer Treatment for Patients with Advanced Solid Tumours

Recruiting

Registered drugNo placebo

Study of ODM-212 in Combination with Cancer Treatment for Patients with Advanced Solid Tumours

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Gemcitabine

Contact Research Centre

Long-Term Safety and Efficacy of KL1333 in Adults with Primary Mitochondrial Disease

Recruiting

InvestigationalNo placebo

Long-Term Safety and Efficacy of KL1333 in Adults with Primary Mitochondrial Disease

InvestigationalNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:2-Isopropyl-3H-Naphtho(1,2-D)Imidazole-4,5-Dione

Contact Research Centre

Colorectal cancer metastatic

Recruiting

INCA33890 With Standard Chemotherapy and Bevacizumab in First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

Registered drug

INCA33890 With Standard Chemotherapy and Bevacizumab in First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

Registered drug

Denmark

Participants:18–64 years · 65+ years
Substances:Bevacizumab

Contact Research Centre

Systemic lupus erythematosus

Recruiting

Nipocalimab in Adults with Moderate to Severe Systemic Lupus Erythematosus

Investigational

Nipocalimab in Adults with Moderate to Severe Systemic Lupus Erythematosus

Investigational

Denmark

Participants:18–64 years · 65+ years
Substances:Nipocalimab

Contact Research Centre

Find therapies in clinical trials near you – page 8

1 509 trials match your criteria

Age-related macular degeneration

A Phase 2/3 Study of intravitreal mk-8748 versus aflibercept in adults with neovascular age‑related macular degeneration

Factor VIII deficiency

Evaluation of NXT007 versus Emicizumab Prophylaxis in Patients with Hemophilia A

Factor VIII deficiency

A Phase III study of NXT007 compared with simoctocog alfa prophylaxis in patients with Hemophilia A without inhibitors

Alpha-1 antitrypsin deficiency

Efficacy and safety of human alpha1‑proteinase inhibitor weekly infusions in adults with alpha1 antitrypsin deficiency–related emphysema

Rheumatoid arthritis

Long‑Term Safety and Efficacy of RO7790121 in Adults with Moderate to Severe Rheumatoid Arthritis: Extension Study

Crohn's disease

A Phase 3b Study of Guselkumab Compared with Risankizumab in Adults with Moderately to Severely Active Crohn’s Disease

Neoplasm

Safety and Efficacy of Ifinatamab Deruxtecan in Pediatric Patients Under 18 With Relapsed or Refractory Solid Tumors

Sepsis+1

Acetylcysteine for Adults with Acute Infection or Sepsis and Liver Dysfunction

Study of ODM-212 in Combination with Cancer Treatment for Patients with Advanced Solid Tumours

Study of ODM-212 in Combination with Cancer Treatment for Patients with Advanced Solid Tumours

Long-Term Safety and Efficacy of KL1333 in Adults with Primary Mitochondrial Disease

Long-Term Safety and Efficacy of KL1333 in Adults with Primary Mitochondrial Disease

Colorectal cancer metastatic

INCA33890 With Standard Chemotherapy and Bevacizumab in First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

Systemic lupus erythematosus

Nipocalimab in Adults with Moderate to Severe Systemic Lupus Erythematosus

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.